Optimi Health Dealer’s License Granted by Health Canada

Psychedelic Research Bulletin: January 2022

Psychedelic Bulletin: Patent Granted Covering DMT Vapes; Microdosing Produces “Negligible” Effects

PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

Religious Practice Under Oregon Measure 109

Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Looking Ahead to a Psychedelic 2022

Entheon Biomedical Announces the Approval of DMT Clinical Trial

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...

Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...

Load more